Assignee
ABBOTT BIOTHERAPEUTICS CORP
US·6 granted patents·1 pending application·110 citations·filing 2004–2011
Top patents by PatentIndex Score
7 records- 0197US8008450B2Therapeutic use of anti-CS1 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2009·Granted Aug 30, 2011·64 cites·4 claims
- 0290US7947495B2Immunoglobulin display vectorsABBOTT BIOTHERAPEUTICS CORP·Filed 2008·Granted May 24, 2011·18 cites·16 claims
- 0388US8349330B2Therapeutic use of anti-CS1 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2011·Granted Jan 8, 2013·8 cites·16 claims
- 0481US8017116B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Sep 13, 2011·3 cites·4 claims
- 0579US7935793B2Treatment of inflammatory bowel diseases with anti-IP-10 antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2004·Granted May 3, 2011·17 cites·12 claims
- 0663US7897148B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Mar 1, 2011·0 cites·8 claims
- 0748US2011070231A1Stable liquid pharmaceutical formulation of igg antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →